| Mike Hooven |

Founder and Chief Technology Officer, AtriCure AtriCure is a Medical Device company that manufactures and sells surgical devices designed to create precise lesions in soft tissue. Cardiothoracic Surgeons have rapidly adopted the AtriCure system to treat Atrial Fibrillation (AF), the world’s most common cardiac rhythm disease and a major cause of stroke and heart failure. AtriCure has grown rapidly to become the market leader, with over 16,000 procedures performed. The AtriCure system is currently being used in 23 of the top 25 heart centers in the United States. AtriCure completed a successful Initial Public Offering on August 5, 2005.
Mike previously held positions as the Chairman and CEO of AtriCure, and the Founder and Chairman of Enable Medical, a surgical device manufacturer that was acquired by AtriCure in August of 2005. Mike founded Enable in April of 1994, and prior to that he was Director of Product Development at Ethicon Endo-Surgery from 1988 to 1994. Mike held Engineering positions at Siemens/Pacesetter from 1986 to 1988, and at Cordis Corporation from 1981 to 1986. He earned a Bachelor of Science in Physics and a Master of Science in Mechanical Engineering from the University of Michigan.
|